drugset / Press release

Polyoxidonium® — now for veterinary use

2011-02-02 · NPO Petrovax · original petrovax.com ↗

Petrovax Group registers the Polyoxidonium®-vet solution. Petrovax Group, a Russian-based developer and manufacturer of innovative medicines and vaccines, has registered Polyoxidonium®-vet solution (Registration Certificate 32-3-8.0-0058 No. PVR-3-8.0/02643) for veterinary use. The equivalent of the well-known Polyoxidonium® will be rolled out for the veterinary market in March this year. Polyoxidonium®-vet will expand the company’s product portfolio which previously exclusively featured unique drugs for major human diseases. Now that veterinarians have access to the comprehensive medicine Polyoxidonium®-vet solution, the health of our pets too can be well protected. What are its key advantages? A unique combination of pharmacological properties (immunomodulatory, detoxicant, antioxidant) ensuring a comprehensive impact on the patient Unlike other immunomodulators, Polyoxidonium®-vet not only restores immunity, but also quickly and effectively clears the system of the infectious agent and its toxins, alleviating the disease symptoms and precipitating a faster recovery Effectively treats viral, bacterial, and fungal diseases Low-hazard substance (Class 4 hazard under GOST 12.1.007-76) Highly-tolerable for animals of any species and age Can be combined with antibiotics, antiviral, antifungal and antihistamine drugs, glucocorticosteroids, cytostatics, and sulfanilamides. The unique combination of immunomodulating, detoxicant, and antioxidant properties makes Polyoxidonium®-vet solution your medicine of choice for: treating acute and chronic bacterial, viral, or fungal infectious diseases quick alleviation of intoxication symptoms in cases of poisoning, acute allergic and toxic allergic reactions mitigating the nephrotoxic and hepatotoxic effects of chemotherapy and drugs decreasing the incidence of infectious complications preventing post-surgery complications palliative treatment of oncological and chronic sufferers or ageing animals enhancing the resistance to adverse environmental factors (weaning, regrouping, transportation, dietary changes) Polyoxidonium®-vet is manufactured in the form of a sterile solution, in ampoules No 5 of two dosages: 3 mg and 6 mg. The product is available through the veterinary drugs subdivision of VETMARKET, tel.: +7 495 777 60 82.

The release as fetched from its publisher. petrovax.com ↗